These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. When can empiric therapy for intensive care unit-acquired pneumonia be withheld or withdrawn? Koeman M; Bonten MJ Semin Respir Infect; 2003 Jun; 18(2):122-8. PubMed ID: 12840793 [TBL] [Abstract][Full Text] [Related]
3. Therapy for ventilator-associated pneumonia: what works, what doesn't. Hijazi M; Al-Ansari M Respir Care Clin N Am; 2004 Sep; 10(3):341-58, vi. PubMed ID: 15458732 [TBL] [Abstract][Full Text] [Related]
7. What is ventilator-associated pneumonia and why is it important? Kollef MH Respir Care; 2005 Jun; 50(6):714-21; discussion 721-4. PubMed ID: 15913464 [TBL] [Abstract][Full Text] [Related]
8. Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. Mehta RM; Niederman MS J Intensive Care Med; 2003; 18(4):175-88. PubMed ID: 15035764 [TBL] [Abstract][Full Text] [Related]
9. Levofloxacin in the treatment of ventilator-associated pneumonia. Alvarez-Lerma F; Grau S; Alvarez-Beltrán M Clin Microbiol Infect; 2006 May; 12 Suppl 3():81-92. PubMed ID: 16669931 [TBL] [Abstract][Full Text] [Related]
10. Bacterial isolates from mechanically ventilated patients with nosocomial pneumonia within intensive care unit of a tertiary care center. Nag VL; Ayyagari A; Venkatesh V; Dash NR; Ghar M; Prasad KN J Commun Dis; 2005 Dec; 37(4):281-7. PubMed ID: 17278658 [TBL] [Abstract][Full Text] [Related]
11. Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines. Kuti JL; Shore E; Palter M; Nicolau DP Semin Respir Crit Care Med; 2009 Feb; 30(1):102-15. PubMed ID: 19199192 [TBL] [Abstract][Full Text] [Related]
12. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit. Chastre J; Luyt CE; Combes A; Trouillet JL Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519 [TBL] [Abstract][Full Text] [Related]
13. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia. Combes A; Luyt CE; Trouillet JL Semin Respir Crit Care Med; 2006 Feb; 27(1):23-8. PubMed ID: 16508878 [TBL] [Abstract][Full Text] [Related]
15. [Microbiological diagnostic and antibiotic management of community aquired and nosocomial pneumonias in intensive care units in Germany]. Meyer E; Ebner W; Heininger A; Schwab F; Rüden H; Daschner FD Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Feb; 40(2):85-90. PubMed ID: 15714398 [No Abstract] [Full Text] [Related]
16. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines. File TM Clin Infect Dis; 2010 Aug; 51 Suppl 1():S42-7. PubMed ID: 20597671 [TBL] [Abstract][Full Text] [Related]
17. [Strategies in the treatment of infections with antibiotics in intensive care medicine]. Deja M; Nachtigall I; Halle E; Kastrup M; Guill MM; Spies CD Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):108-15. PubMed ID: 17309018 [TBL] [Abstract][Full Text] [Related]
19. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Niederman MS Clin Infect Dis; 2006 Jan; 42 Suppl 2():S72-81. PubMed ID: 16355320 [TBL] [Abstract][Full Text] [Related]
20. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems. Kollef MH Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]